Click on image to view larger version.

Figure 1 Vascular endothelial growth factor (VEGF) and endostatin levels in patients grouped with respect to gender, presence or absence of diabetes mellitus (DM), acute coronary syndrome (ACS) (present or absent), and ejection fraction (EF) (<35% or >35%). There are no statistically significant differences shown in either VEGF or endostatin with respect to any of these factors.